Sana Biotechnology, Inc. (NASDAQ:SANA) appears in 197 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| FMR LLC | 31 Mar, 2026 | 37,430,284 | 0 | 0.00% | $107,799,219.00 |
| FMR LLC | 31 Mar, 2026 | 37,430,284 | -1,081 | 0.00% | $152,341,256.00 |
| Flagship Pioneering, LLC | 31 Mar, 2026 | 25,001,856 | 0 | 0.00% | $101,757,555.00 |
| Flagship Pioneering, LLC | 31 Mar, 2026 | 25,001,856 | 0 | 0.00% | $72,005,346.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 14,240,175 | 16,648 | 0.12% | $41,011,704.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 14,223,527 | 2,997,391 | 26.70% | $57,889,754.00 |
| State Street Corp | 31 Mar, 2026 | 10,538,086 | 2,483,245 | 30.83% | $30,349,688.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 10,455,195 | 1,326,222 | 14.53% | $42,552,645.00 |
| CANADA PENSION PLAN INVESTMENT BOARD | 31 Mar, 2026 | 10,242,100 | 67,100 | 0.66% | $41,685,347.00 |
| CANADA PENSION PLAN INVESTMENT BOARD | 31 Mar, 2026 | 10,221,900 | -20,200 | -0.20% | $29,439,072.00 |
| State Street Corp | 31 Mar, 2026 | 8,054,841 | 1,374,300 | 20.57% | $32,783,203.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 7,434,724 | 7,434,724 | 0.00% | $21,412,005.00 |
| BAILLIE GIFFORD & CO | 31 Mar, 2026 | 6,609,065 | 0 | 0.00% | $19,034,107.00 |
| BAILLIE GIFFORD & CO | 31 Mar, 2026 | 6,609,065 | -4,827,438 | -42.21% | $26,898,895.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,181,973 | 63,835 | 1.55% | $12,046,360.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 4,118,138 | 694,606 | 20.29% | $16,763,171.00 |
| Marex Group plc | 31 Mar, 2026 | 3,999,100 | 266,320 | 7.13% | $11,517,408.00 |
| Marex Group plc | 31 Mar, 2026 | 3,732,780 | -90,000 | -2.35% | $15,192,415.00 |
| Integral Health Asset Management, LLC | 31 Mar, 2026 | 3,200,000 | 200,000 | 6.67% | $9,216,000.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,181,115 | 204,361 | 6.87% | $9,161,611.00 |